No Data
No Data
Estimating The Intrinsic Value Of Artivion, Inc. (NYSE:AORT)
Needham Maintains Artivion(AORT.US) With Buy Rating, Maintains Target Price $30
Buy Rating for Artivion's Stock on Promising AMDS Outlook and Financial Impact
Those Who Invested in Artivion (NYSE:AORT) a Year Ago Are up 61%
Can Artivion's Strong Vital Signs Lead To Further Stock Gains?
Stifel Maintains Artivion(AORT.US) With Buy Rating, Maintains Target Price $30